Topical Canrenoic Acid.
- 1 November 1991
- journal article
- research article
- Published by Wiley in International Journal of Dermatology
- Vol. 30 (11) , 810-813
- https://doi.org/10.1111/j.1365-4362.1991.tb04794.x
Abstract
The topical antiandrogenic activity of potassium canrenoate (CAK), compared with that of spironolactone (SP), was assayed in vivo in female golden Syrian hamsters whose flank organs were stimulated by subcutaneous administration of testosterone propionate. Sebaceous glands and hair were measured by a computerized image analyzer. Pigmented spots, sebaceous gland areas, and the diameter of hairs of the treated flank organs were smaller in the groups that received CAK (1.6 mg/day) and SP (0.4 mg/day). The authors' results showed that CAK may act as a topical antiandrogen on the hamster flank organ when applied in concentrations four times greater than the minimal active dosage of SP. Potassium canrenoate may be a useful weak topical antiandrogen, and it could be used in androgen-related skin disorders involving both sebaceous glands and hair, especially in men. These concentrations could be verified by additional clinical investigations.Keywords
This publication has 11 references indexed in Scilit:
- Epitestosterone: A Potential New AntiandrogenJournal of Investigative Dermatology, 1987
- Antiandrogenic effects of topically applied spironolactone on the hamster flank organArchives of Dermatology, 1985
- Oral spironolactone improves acne vulgaris and reduces sebum excretionBritish Journal of Dermatology, 1984
- The stimulation of hair growth in the flank organs of female hamsters by subcutaneous testosterone propionate and its inhibition by topical cyproterone acetate: dose-response studiesBritish Journal of Dermatology, 1983
- Antiandrogenic properties of spironolactone. Clinical trial in the management of female hirsutismJournal of Endocrinological Investigation, 1983
- Relation of Canrenone to the Actions of Spironolactone on Adrenal Cytochrome P-450-Dependent Enzymes*Endocrinology, 1978
- Spironolactone and canrenoate‐K: Relative potency at steady stateClinical Pharmacology & Therapeutics, 1977
- Interaction of Spironolactone and Digitalis with the 5α Dihydrotestosterone (DHT)1Receptor of Rat Ventral Prostate1Endocrinology, 1975
- Antiandrogenic Effect of Spirolactones: Mechanism of ActionEndocrinology, 1975
- Spironolactone and cytochrome P-450: Impairment of steroid hydroxylation in the adrenal cortexLife Sciences, 1974